Abbott | ABT - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 299M 231M 2026-06
Agilent USD 25M 0 2026-03
AtriCure USD 1.37M 42K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 149M 4M 2026-03
Bio-Rad Laboratories USD 12.1M 200K 2025-12
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 20.9M 1.5M 2026-03
Danaher USD 63M 8M 2026-03
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 5.44B 5.44B 2026-03
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
Intuitive Surgical USD 20.11B 58.39B 2026-03
J&J USD 43M 25M 2026-03
Medtronic USD 176M 5M 2026-03
Merit Medical Systems USD 6.53M 162K 2026-03
Pfizer USD 671M 40M 2026-03
Smith & Nephew USD 69M 1000K 2025-12
Solventum Corp USD 14.1B 14.05B 2026-03
Stryker USD 46.29B 45.68B 2026-03
Tandem Diabetes Care USD 1.15B 1.15B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Terumo JPY 1.53B 1.06B 2026-03
Thermo Fisher Scientific USD 354M 11M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03